Overexpression of Septin1: Possible contribution to the development of oral cancer

International Journal of Oncology

Volumn 31, Issue 5, 2007, Pages 1021-1028

  Kato, Yoshikuni ^a   Uzawa, Katsuhiro ^a,b   Yamamoto, Nobuharu ^c   Kouzu, Yukinao ^a   Koike, Hirofumi ^a   Shiiba, Masashi ^b   Bukawa, Hiroki ^b   Yokoe, Hidetaka ^b   Shibahara, Takahiko ^c   Tanzawa, Hideki ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Cytokinesis; Oral squamous cell carcinoma; Potential markers; Septin1

Indexed keywords

DGTPASE; PHOSPHATASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES;

EID: 38449114458     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Lippman SM, Sudbo J and Hong WK: Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23: 346-356, 2005. (Pubitemid 46206883)
2. Larsson T, Bergstrom J, Nilsson C and Karlsson KA: Use of an affinity proteomics approach for the identification of low-abundant bacterial adhesions as applied on the Lewis (b)-binding adhesion of Helicobacter pylori. FEBS Lett 469: 155-158, 2000.
3. Charlwood J, Skehel JM and Camilleri P: Analysis of N-linked oligosaccharides released from glycoproteins separated by two-dimensional gel electrophoresis. Anal Biochem 284: 49-59, 2001.
4. Wilkins MR, Sanchez JC, Gooley AA, Appel RD, Humphery-Smith L, Hochstrasser DF and Williams KL: Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev 13: 19-50, 1996.
5. Pandey A and Mann M: Proteomics to study genes and genomes. Nature 405: 837-846, 2000.
6. Rudert F: Genomics and proteomics tools for the clinic. Curr Opin Mol Ther 2: 633-642, 2000.
7. Koike H, Uzawa K, Nakashima D, Shimada K, Kato Y, Higo M, Kouzu Y, Endo Y, Kasamatsu A and Tanzawa H: Identification of differentially expressed proteins in oral squamous-cell carcinoma using a global proteomic approach. Int J Oncol 27: 59-67, 2005.
8. Takahashi K, Kanazawa H, Akiyama Y, Tazaki S, Takahara M, Muto T and Sato K: Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous-cell carcinoma of the tongue. J Jpn Stomatol Soc 38: 20-28, 1989.
9. Skoufias DA, Mollinari C, Lacroix FB, Wilson L and Margolis RL: Human survivin is a kinetochore-associated passenger protein. J Cell Biol 151: 1575-1581, 2000.
10. Endo Y, Uzawa K, Mochida Y, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Sarcoendoplasmic reticulum Ca(2+) ATPase type 2 downregulated in human oral squamous-cell carcinoma. Int J Cancer 110: 225-231, 2004.
11. Kasamatsu A, Uzawa K, Nakashima D, Koike H, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Galectin-9 as a regulator of cellular adhesion in human oral squamous-cell carcinoma cell lines. Int J Mol Med 16: 269-273, 2005.
12. Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of RAB1A in human tongue cancer. Br J Cancer 92: 1915-1921, 2005.
13. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H and Tanzawa H: Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 82: 607-611, 2003.
14. Hanash SM, Strahler JR, Kuick R, Chu EHY and Nichols D: Identification of a polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem 263: 12813-12815, 1988.
15. Hanash SM: Biomedical applications of two-dimensional electrophoresis using immobilized pH gradients: current status. Electrophoresis 21: 1202-1209, 2000.
16. Prasannan L, Misek DE, Hinderer R, Michon J, Geiger JD and Hanash SM: Identification of β-tubulin isoforms as tumor antigens in neuroblastoma. Clin Cancer Res 6: 3949-3956, 2000.
17. Liotta L and Petricoin E: Molecular profiling of human cancer. Nat Rev Genet 1: 48-56, 2000.
18. Emmert-Buck MR, Gillespie JW, Paweletz CP, Ornstein DK, Basrur V, Appella E, Wang QH, Huang J, Hu N, Taylor P and Petricoin EF: An approach to proteomic analysis of human tumors. Mol Carcinog 27: 158-165, 2000.
19. Kinoshita M, Kumar S, Mizoguchi A, Ide C, Kinoshita A, Haraguchi T, Hiraoka Y and Noda M: Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures. Genes Dev 11: 1535-1547, 1997.
20. Field CM and Kellogg D: Septins, cytoskeletal polymers or signalling GTPases? Trends Cell Biol 9: 387-394, 1999.
21. Hsu SC, Hazuka CD, Roth R, Foletti DL, Heuser J and Scheller RH: Subunit composition, protein interactions, and structures of the mammalian brain sec6/8 complex and septin filaments. Neuron 20: 1111-1122, 1998.
22. Kinoshita M, Field CM, Coughlin ML, Straight AF and Mitchison TJ: Self- and actin-templated assembly of mammalian septins. Dev Cell 3: 791-802, 2002.
23. Joberty G, Perlungher RR, Sheffield PJ, Kinoshita M, Noda M, Haystead T and Macara IG: Borg proteins control septin organisation and are negatively regulated by Cdc42. Nat Cell Biol 3: 861-866, 2001.
24. Xie H, Surka M, Howard J and Trimble WS: Characterization of the mammalian septin H5: distinct patterns of cytoskeletal and membrane association from other septin proteins. Cell Motil Cytoskeleton 43: 52-62, 1999.
25. Zhang J, Kong C, Xie H, McPherson PS, Grinstein S and Trimble WS: Phosphatidylinositol polyphosphate binding to the mammalian septin H5 is modulated by GTP. Curr Biol 9: 1458-1467, 1999.
26. Nagata KI, Kawajiri A, Matsui S, Takagishi M, Shiromizu T, Saitoh N, Izawa I, Kiyono T, Itoh TJ, Hotani H and Inagaki M: Filament formation of MSF-A, a mammalian septin, in mammary HMEC cells depends on interactions with microtubules. J Biol Chem 278: 18538-18543, 2003.
27. Surka MC, Tsang CW and Trimble WS: The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol Biol Cell 13: 3532-3545, 2002.
28. Beites CL, Xie H, Bowser R and Trimble WS: The septin CDCrel-1 binds syntaxin and inhibits exocytosis. Nat Neurosci 2: 434-439, 1999.
29. Meiyan Q, Wenbo Y, Shen L, Huijue J, Lisha T, Mingjuan S, Xiaomei Y, Hexige S, Qingyu L, Bo W, Shouyuan Z and Long Y: Septin1, a new interaction partner for human serine/threonine kinase aurora-B. Biochem Biophys Res Commun 336: 994-1000, 2005.
30. Murata-Hori M, Tatsuka M and Wang YL: Probing the dynamics and functions of Aurora-B kinase in living cells during mitosis and cytokinesis. Mol Biol Cell 13: 1099-1108, 2002.
31. Terada Y, Tatsuka M, Suzuki F, Yasuda Y, Fujita S and Otsu M: AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J 17: 667-676, 1998.
32. Schumacher JM, Golden A and Donovan PJ: AIR-2: an Aurora/Ipl1-related protein kinase associated with chromosomes and midbody microtubules is required for polar body extrusion and cytokinesis in Caenorhabditis elegans embryos. J Cell Biol 143: 1635-1646, 1998.
33. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ and Plowman GD: A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17: 3052-3065, 1998.
34. Chieffi P, Troncone G, Caleo A, Libertini S, Linardopoulos S, Tramontano D and Portella G: Aurora B expression in normal testis and seminomas. J Endocrinol 181: 263-270, 2004.
35. Sorrentino R, Libertini S, Pallante PL, Troncone G, Palombini L, Bavetsias V, Spalletti Cernia D, Laccetti P, Linardopoulos S, Chieffi P, Fusco A and Portella G: Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J Clin Endocrinol Metab 90: 928-935, 2005.
36. Smith SL, Bowers NL, Betticher DC, Gautschi O, Ratschiller D, Hoban PR, Booton R, Santibanes-Koref MF and Heighway J: Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br J Cancer 93: 719-729, 2005.